Quanterix (QTRX) Return on Capital Employed Growth (1y) (2019 - 2026)
Quanterix (QTRX) Return on Capital Employed Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -81.00 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1,390.00 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 39.00 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -110.00 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 658.00 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 125.00 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -3,185.00 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Quanterix | 184.16 Mn | 84.89 Mn | 15.57 Mn | -2,332.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,332.00 |
| Dec 31, 2025 | -2,085.00 |
| Sep 30, 2025 | -2,110.00 |
| Jun 30, 2025 | -1,270.00 |
| Mar 31, 2025 | -466.00 |
| Dec 31, 2024 | -255.00 |
| Sep 30, 2024 | 4.00 |
| Jun 30, 2024 | 607.00 |
| Mar 31, 2024 | 1,108.00 |
| Dec 31, 2023 | 1,375.00 |
| Sep 30, 2023 | 929.00 |
| Jun 30, 2023 | -309.00 |
| Mar 31, 2023 | -1,040.00 |
| Dec 31, 2022 | -1,349.00 |
| Sep 30, 2022 | -1,302.00 |
| Jun 30, 2022 | -1,060.00 |
| Mar 31, 2022 | -558.00 |
| Dec 31, 2021 | 182.00 |
| Mar 31, 2021 | 2,079.00 |
| Dec 31, 2020 | 1,334.00 |